healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
With the public health emergency scheduled to expire, the DEA has proposed rules that put patients at risk of “not getting critical, clinically appropriate medications, which in turn puts their lives at risk,” said Dr. Joseph Kvedar. In this blog, he provides information on how leaders can get involved and help prevent a “potential public health crisis.”
The key to restoring trust in telehealth is in addressing the “underlying issues that are raising concerns in the first place,” according to Joseph Kvedar, MD. In this blog, he discusses the steps the ATA is taking, and the lessons healthcare can learn from other industries.
Despite the fact that CMS has extended the public health emergency that expanded telemedicine coverage, a number of states aren’t on board, according to Dr. John Halamka and Paul Cerrato. “Finding a way to extend the regulatory waivers,” they write, “is in our patients’ best interest.”
The answer to the most basic question surrounding telehealth — ‘Is it as good as in-person care?’ — is anything but simple, according to Dr. Joseph Kvedar. In this piece, he examines the pros and cons of different types of clinical research and shares examples from recent literature that can help uncover some answers.
The virtual care model isn’t perfect, but it can “effectively address the needs of challenging patient populations, including those requiring virtual management of controlled substances,” according to Joseph Kvedar, MD, Senior Advisor of Virtual Care at Mass General Brigham.
